請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58042完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 潘子明 | |
| dc.contributor.author | Yen-De Liu | en |
| dc.contributor.author | 劉彥德 | zh_TW |
| dc.date.accessioned | 2021-06-16T08:04:59Z | - |
| dc.date.available | 2019-07-16 | |
| dc.date.copyright | 2014-07-16 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-06-26 | |
| dc.identifier.citation | 張剛。2007。乳酸細菌—基礎、技術和應用。化學工業出版社。北京。中國。
Andrew, H.M., and Charles, L.R. (2008). Immune system contributions to the pathophysiology of depression. Focus 6: 26-45. Adams, C.A. (2010). The probiotic paradox: live and dead cells are biological response modifiers. Nutr. Res. Rev. 23: 37-46. Aiba, Y., Suzuki, N., Kabir, A.M., Takagi, A., and Koga, Y. (1998). Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 93: 2097-2101. Asong, J., Wolfert, M.A., Maiti, K.K., Miller, D., and Boons, G.J. (2009). Binding and cellular activation studies reveal that toll-like receptor 2 can differentially recognize peptidoglycan from gram-positive and gram-negative bacteria. J. Biol. Chem. 284: 8643-8653. Barnes, P.J. (1999). Effect of beta-agonists on inflammatory cells. J. Allergy. Clin. Immunol. 104: S10-17. Benchimol, E.I., and Mack, D.R. (2004). Probiotics in relapsing and chronic diarrhea. J. Pediatr. Hematol. Oncol. 26: 515-517. Bengmark, S. (2000). Colonic food: pre- and probiotics. Am. J. Gastroenterol. 95: S5-S7. Braman, S.S. (2006). The global burden of asthma. Chest. 130: 4S-12S. Brown, A.C., and Valiere, A. (2004). Probiotics and medical nutrition therapy. Nutr. Clin. Care. 7: 56-68. Cella, M., Sallusto, F., and Lanzavecchia, A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9: 10-16. Chapat, L., Chemin, K., Dubois, B., Bourdet-Sicard, R., and Kaiserlian, D. (2004). Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur. J. Immunol. 34: 2520-2528. Chiang, S.S., and Pan, T.M. (2011). Antiosteoporotic effects of Lactobacillus -fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. J. Agric. Food. Chem. 59: 7734-7742. Chiang, S.S, and Pan, T.M. (2012) Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products. Appl. Microbiol. Biotechnol. 93: 903–916. Chuang, L., Wu, K.G., Pai, C., Hsieh, P.S., Tsai, J.J., Yen, J.H., and Lin, M.Y. (2007). Heat-killed cells of Lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell-treated T cells. J. Agric. Food. Chem. 55: 11080-11086. Davies, A.J. (1993). The tale of T cells. Immunol. Today. 14: 137-139. Dinleyici, E.C., and Vandenplas, Y. (2014). Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta. Paediatr. DOI: 10.1111/apa.12617. Eaton, K.A., Brooks, C.L., Morgan, D.R., and Krakowka, S. (1991). Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59: 2470-2475. Fearon, D.T., and Locksley, R.M. (1996). The instructive role of innate immunity in the acquired immune response. Science. 272: 50-53. Ghildyal, N., Friend, D. S., Freelund, R., Austen, K. F., McNeil, H. P., Schiller, V., and Stevens, R. L. (1994). Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. J. Immunol. 153: 2624-2630. Guandalini, S., Pensabene, L., Zikri, M.A., Dias, J.A., Casali, L.G., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., Papadopoulou, A., de Sousa, J.S., Sandhu, B., Szajewska, H., and Weizman, Z. (2000). Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30: 54-60. Gueders, M.M., Paulissen, G., Crahay, C., Quesada-Calvo, F., Hacha, J., Van Hove, C., Tournoy, K., Louis, R., Foidart, J.M., Noel, A., and Cataldo, D.D. (2009). Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm. Res. 58: 845-854. Hart, A.L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M.A., Knight, S.C., and Stagg, A.J. (2004). Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 53: 1602-1609. Hawrylowicz, C.M., and O'Garra, A. (2005). Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5: 271-283. Hirose, Y., Murosaki, S., Fujiki, T., Yamamoto, Y., Yoshikai, Y., and Yamashita, M. (2010). Lipoteichoic acids on Lactobacillus plantarum cell surfaces correlate with induction of interleukin-12p40 production. Microbiol. Immunol. 54: 143-151. Holgate, S.T., and Polosa, R. (2008). Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8: 218-230. Holzapfel, W.H., Haberer, P., Snel, J., Schillinger, U., and Huis in't Veld, J.H. (1998). Overview of gut flora and probiotics. Int. J. Food. Microbiol. 41: 85-101. Hsu, C. Y., Leu, S. J., Chiang, B. L., Liu, H. E., Su, H. C., and Lee, Y. L. (2010). Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10+IFN-gamma+CD4+ T cells. Gene Therapy. 17: 1011-1021. Imase, K., Tanaka, A., Tokunaga, K., Sugano, H., Ishida, H., and Takahashi, S. (2007). Lactobacillus reuteri tablets suppress Helicobacter pylori infection--a double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi. 81: 387-393. Kim, D.W., Cho, S.B., Lee, H.J., Chung, W.T., Kim, K.H., Hwangbo, J., Nam, I.S., Cho, Y.I., Yang, M.P., and Chung, I.B. (2007a) Comparison of cytokine and nitric oxide induction in murine macrophages between whole cell and enzymatically digested Bifidobacterium sp. obtained from monogastric animals. J. Microbiol. 45: 305-310. Kim, D.W., Cho, S.B., Yun, C.H., Jeong, H.Y., Chung, W.T., Choi, C.W., Lee, H.J., Nam, I.S., Suh, G.H., Lee, S.S., and Lee, B.S. (2007b) Induction of cytokines and nitric oxide in murine macrophages stimulated with enzymatically digested Lactobacillus strains. J. Microbiol. 45: 373-378. Kim, H.Y., DeKruyff, R.H., and Umetsu, D.T. (2010). The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. Immunol. 11: 577-584. Komai-Koma, M., Jones, L., Ogg, G.S., Xu, D., and Liew, F.Y. (2004). TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA. 101: 3029-3034. Kopp-Hoolihan, L. (2001). Prophylactic and therapeutic uses of probiotics: a review. J. Am. Diet. Assoc. 101: 229-238. Lambrecht, B.N., and Hammad, H. (2003). Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 3: 994-1003. Lebeer, S., Vanderleyden, J., and De Keersmaecker, S.C. (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8: 171-184. Li, C. Y., Lin, H. C., Hsueh, K. C., Wu, S. F., and Fang, S. H. (2010). Oral administration of Lactobacillus salivarius inhibits the allergic airway response in mice. Can. J. Microbiol. 56: 373-379. Liew, F.Y. (2002). Th1 and Th2 cells: a historical perspective. Nat. Rev. Immunol. 2: 55-60. Mansson, A., Adner, M., and Cardell, L.O. (2006). Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. DOI: 10.1186/1465-9921-7-36. Meltzer, M.S., Benjamin, W.R., and Farrar, J.J. (1982). Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line. J. Immunol. 129: 2802-2807. Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R.N., and Staiano, A. (2009). Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol. 104: 437-443. Mills, K.H. (2011). TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11: 807-822. Murosaki, S., Yamamoto, Y., Ito, K., Inokuchi, T., Kusaka, H., Ikeda, H., and Yoshikai, Y. (1998). Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J. Allergy. Clin. Immunol. 102: 57-64. Ng, S.C., Hart, A.L., Kamm, M.A., Stagg, A.J., and Knight, S.C. (2009). Mechanisms of action of probiotics: recent advances. Inflamm. Bowel. Dis. 15: 300-310. Oh, Y.C., Cho, W.K., Oh, J.H., Im, G.Y., Jeong, Y.H., Yang, M.C., and Ma, J.Y. (2012). Fermentation by Lactobacillus enhances anti-inflammatory effect of Oyaksungisan on LPS-stimulated RAW 264.7 mouse macrophage cells. BMC. Complement. Altern. Med. DOI: 10.1186/1472-6882-12-17. Pan, D., Luo, Y., and Tanokura, M. (2005). Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004. Food. Chem. 9: 123-129. Parvez, S., Malik, K.A., Ah Kang, S., and Kim, H.Y. (2006). Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 100: 1171-1185. Peluso, I., Fina, D., Caruso, R., Stolfi, C., Caprioli, F., Fantini, M.C., Caspani, G., Grossi, E., Di Iorio, L., Paone, F.M., Pallone, F., and Monteleone, G. (2007). Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation. Infect. Immun. 75: 1730-1737. Pouwels, P.H., and Leer, R.J. (1993) Genetics of Lactobacilli: plasmids and gene expression. Antonie van Leeuwenhoek. 64: 85-107. Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., and Raz, E. (2004). Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 126: 520-528. Rajan, T.V. (2003). The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends. Immunol. 24: 376-379. Rigaux, P., Daniel, C., Hisbergues, M., Muraille, E., Hols, P., Pot, B., Pestel, J., and Jacquet, A. (2009). Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy. 64: 406-414. Saavedra, J. (2000). Probiotics and infectious diarrhea. Am. J. Gastroenterol. 95: S16-S18. Segawa, S., Nakakita, Y., Takata, Y., Wakita, Y., Kaneko, T., Kaneda, H., Watari, J., and Yasui, H. (2008). Effect of oral administration of heat-killed Lactobacillus brevis SBC8803 on total and ovalbumin-specific immunoglobulin E production through the improvement of Th1/Th2 balance. Int. J. Food. Microbiol. 121: 1-10. Sereda, M.J., Hartmann, S., and Lucius, R. (2008). Helminths and allergy: the example of tropomyosin. Trends. Parasitol. 24: 272-278. Smits, H.H., Engering, A., van der Kleij, D., de Jong, E.C., Schipper, K., van Capel, T.M., Zaat, B.A., Yazdanbakhsh, M., Wierenga, E.A., van Kooyk, Y., and Kapsenberg, M.L. (2005). Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy. Clin. Immunol. 115: 1260-1267. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K., and Nagata, S. (1995). Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154: 3806-3813. Taverniti, V., and Guglielmetti, S. (2011). The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes. Nutr. 6: 261-274. Tiwari, G., Tiwari, R., Pandey, S., and Pandey, P. (2012) Promising future of probiotics for human health: Current scenario. Chronicles of Young Scientists. 3: 17-28. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G.M., Forti, G., Morini, S., Hassan, C., Pistoia, M.A., Modeo, M.E., Rodino', S., D'Amico, T., Sebkova, L., Sacca', N., Di Giulio, E., Luzza, F., Imeneo, M., Larussa, T., Di Rosa, S., Annese, V., Danese, S., and Gasbarrini, A. (2010). Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 105: 2218-2227. Ulisse, S., Gionchetti, P., D'Alo, S., Russo, F.P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M.G., Campieri, M., and De Simone, C. (2001). Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol. 96: 2691-2699. Vidal, K., Donnet-Hughes, A., and Granato, D. (2002). Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect. Immun. 70: 2057-2064. von der Weid, T., Bulliard, C., and Schiffrin, E.J. (2001). Induction by a lactic acid bacterium of a population of CD4+ T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab. Immunol. 8: 695-701. von Schillde, M.A., Hormannsperger, G., Weiher, M., Alpert, C.A., Hahne, H., Bauerl, C., van Huynegem, K., Steidler, L., Hrncir, T., Perez-Martinez, G., Kuster, B., and Haller, D. (2012). Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell. Host. Microbe. 11: 387-396. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58042 | - |
| dc.description.abstract | 近年來，有過敏體質的人越來越多，其中最常見的第一型過敏反應為氣喘，尤以兒童族群最為嚴重。全台約每十個小孩就有一人患有氣喘或過敏反應，在大台北等都會區更高達 15-20%，且全台氣喘盛行率逐年攀升，不僅增加社會與醫療成本，更是家庭中的經濟與生活負擔。本研究以實驗室所分離之本土乳酸桿菌，包含副乾酪乳酸桿菌 NTU 101 與胚芽乳酸桿菌 NTU 102，以細胞平台與動物模式探討免疫調節之機轉。首先利用 EL-4 T 細胞株初步篩選出具免疫調節潛力的菌株，結果顯示副乾酪乳酸桿菌 NTU 101 除了能提升 Th1 細胞激素如 IFN-γ 之分泌外，能同時抑制 Th2 細胞激素如 IL-4、IL-5 與 IL-13之表現，效果皆優於胚芽乳酸桿菌 NTU 102，而主要活性之區分物存在於熱致死菌與酵素水解菌體後離心所得之沉澱物。此外以 OVA 刺激 BALB/c 小鼠誘導其成為過敏動物模式，研究顯示每日口服副乾酪乳酸桿菌 NTU 101 熱致死菌亦能調降體內血清與脾臟之 IgE 抗體的生成。在同時餵食乳酸菌與致敏的模式中，乳酸菌之主要調控機轉是藉由提升 IFN-γ 分泌與抑制 IL-4 及 IL-13 之表現，但對於 IL-5 則無顯著差異，因此顯示口服熱致死乳酸桿菌即可達到平衡 Th1/Th2 與緩解過敏症狀之功效。 | zh_TW |
| dc.description.abstract | Hypersensitivity has become more and more common around the world. Asthma is the most common type of hypersensitivity, especially in children. There are approximately 10% of children who suffered from asthma or hypersensitivity in Taiwan and more severe in metropolitan cities. The prevalence of asthma has markedly increased in Taiwan in recent decades which not only raised the social and medical costs but also deteriorated family burden and quality of life. This study focuses on the immunomodulatory effects of local lactic acid bacteria, namely Lactobacillus paracasei subsp. paracasei NTU 101 and Lactobacillus plantarum NTU 102, both in vitro and in vivo. We screened out potential immunomodulting candidates of Lactobacillus by EL-4 T cells. Lactobacillus paracasei subsp. paracasei NTU 101 exerted beneficial effects by increasing Th1 cytokine production of IFN-γ and by surpressing secretion of IL-4, IL-5 and IL-13. Additionally, effective hydrolysates were found in heat-killed and enzymatic hydrolyzed Lactobacillus. Moreover, the results showed that daily gavage of heat-killed Lactobacillus paracasei subsp. paracasei NTU 101 in OVA-induced allergic mice can reduce IgE secretion both in serum and spleen. Evidence for the basis of modulatory effects of Lactobacillus comes from increasing the expression of IFN-γ while decreasing the secretion of IL-4 and IL-13 at the same time in co-treatment of Lactobacillus with OVA-induced allergic mice. The results indicated that oral administration of heat-killed Lactobacilli can not only balance the activity of Th1/Th2 but also relieve the symptoms from hypersensitivity. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T08:04:59Z (GMT). No. of bitstreams: 1 ntu-103-R01b22021-1.pdf: 2514261 bytes, checksum: e946754ae146adaa6594d9c17210d5a8 (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 目錄……………………………………………………………………………………… i
表目錄…………………………………………………………………………………… iii 圖目錄…………………………………………………………………………………… iv 縮寫表…………………………………………………………………………………… vii 中文摘要………………………………………………………………………………… ix 英文摘要………………………………………………………………………………… x 第壹章 文獻回顧…………………………………………………………………….…. 1 一、免疫系統與過敏疾病之回顧與研究……………………………………………… 1 (一) 先天免疫與後天免疫之介紹………………………………………………….… 1 (二) 過敏反應…………………………………………………….…………………… 8 (三) 現今治療方式之比較………………………………………….………………… 10 二、乳酸菌之文獻回顧………………………………………………………………… 15 (一) 乳酸菌之特性…………………………………………………….……………… 15 (二) 乳酸菌的應用與價值……………………………………………………………. 15 三、乳酸菌與免疫調節之文獻回顧…………………………………………………… 22 (ㄧ) 乳酸菌的免疫調節機轉………………………………………………….……… 22 (二) 菌體區分物與調控機轉………………………………………………….……… 25 第貳章 研究動機與目的……………………………………………………………….. 31 第參章 材料與方法…………………………………………………………………….. 34 ㄧ、實驗材料…………………………………………………………………………… 34 (一) 儀器設備………………………………………………………………………….. 34 (二) 一般藥品………………………………………………………………………….. 34 (三) 乳酸桿菌培養基………………………………………………………………….. 35 (四) 細胞激素套組…………………………………………………………………….. 35 二、實驗方法…………………………………………………………………………… 36 (一) 乳酸菌樣品製備………………………………….……….……….……………... 36 (二) 細胞模式之試驗方法……………………………….……….……….…………... 37 (三) 動物模式之試驗方法………………………………….……….……….………... 39 第肆章 結果與討論…………………………………………………………………….. 44 一、乳酸菌樣品對於體外細胞試驗之評估…………………………………………… 44 (一) 以 EL-4 T 細胞株建立評估平台……………………………………………….. 44 (二) 同時致敏組………………………………………………………………………. 47 (三) 後致敏組……………………………………………………………………..…... 52 (四) 綜合比較…………………………………………………………………….…… 57 二、乳酸菌樣品對於動物平台試驗之評估…………………………………………… 57 (一) 血清與脾臟之 IgE 抗體試驗…………………………………………………… 58 (二) 同時處理組…………………………………………………………………….… 58 (三) 後致敏組…………………………………………………………………….…… 65 (四) 綜合比較…………………………………………………………………….…… 70 第伍章 結論…………………………………………………………………………….. 75 第陸章 參考文獻……………………………………………………………………….. 76 | |
| dc.language.iso | zh-TW | |
| dc.subject | 細胞激素 | zh_TW |
| dc.subject | 過敏 | zh_TW |
| dc.subject | EL-4 T 細胞株 | zh_TW |
| dc.subject | 免疫調節 | zh_TW |
| dc.subject | 乳酸桿菌 | zh_TW |
| dc.subject | allergy | en |
| dc.subject | cytokine | en |
| dc.subject | EL-4 T cell | en |
| dc.subject | immunomodulation | en |
| dc.subject | Lactobacillus | en |
| dc.title | 副乾酪乳酸桿菌 NTU 101 與胚芽乳酸桿菌 NTU 102 對於 EL-4 T 細胞株與過敏原誘發之小鼠之免疫調節功效 | zh_TW |
| dc.title | Immunomodulatory effects of administration of Lactobacillus paracasei subsp. paracasei NTU 101 and Lactobacillus plantarum NTU 102 on EL-4 T cell and OVA-induced allergic mice | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 謝淑貞,蔣慎思,陳明汝,蔡宗佑 | |
| dc.subject.keyword | 乳酸桿菌,免疫調節,EL-4 T 細胞株,過敏,細胞激素, | zh_TW |
| dc.subject.keyword | Lactobacillus,immunomodulation,EL-4 T cell,allergy,cytokine, | en |
| dc.relation.page | 84 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2014-06-27 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科技學系 | zh_TW |
| 顯示於系所單位： | 生化科技學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf 未授權公開取用 | 2.46 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。